Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - COMMON STOCK
Common Stock ALLO - Allogene Therapeutics, Inc.
169 K
LAST VALUE
9.09%
2 YEAR CAGR
6.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR